Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 1 feed behind: Congress trades, 12 days · Every feed →

All 7,435Congress 2,157Executive branch 468Insiders 4,810
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

filed late · 7,435 trades

Trades
7,435
Buys 2,846 · Sells 4,585
People
1,291
Stocks
1,542
Disclosed value
$7.7B
range midpoints · Congress & executive
Filed late
7,435
  1. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$719Kdisclosed Jun 10 · filed 82 days after the trade · late
  2. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$9.6Kdisclosed Jun 10 · filed 6 days after the trade · late
  3. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$101Kdisclosed Jun 10 · filed 97 days after the trade · late
  4. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$89.3Kdisclosed Jun 10 · filed 75 days after the trade · late
  5. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$2.6Kdisclosed Jun 10 · filed 12 days after the trade · late
  6. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.6Kdisclosed Jun 10 · filed 12 days after the trade · late
  7. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  8. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.5Mdisclosed Jun 10 · filed 83 days after the trade · late
  9. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$28.8Kdisclosed Jun 10 · filed 77 days after the trade · late
  10. ▲ BUYAmy L Reasner DirectorQCRH Qcr Holdings Inc$5.4Kdisclosed Jun 10 · filed 8 days after the trade · late
  11. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$31.5Kdisclosed Jun 10 · filed 8 days after the trade · late
  12. ▼ SELLJian Irish DirectorMGX Metagenomi Therapeutics, Inc.$4.9Kdisclosed Jun 10 · filed 5 days after the trade · late
  13. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$1.1Kdisclosed Jun 10 · filed 7 days after the trade · late
  14. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  15. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$5.3Kdisclosed Jun 10 · filed 20 days after the trade · late
  16. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 85 days after the trade · late
  17. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$1.1Mdisclosed Jun 10 · filed 75 days after the trade · late
  18. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$970disclosed Jun 10 · filed 6 days after the trade · late
  19. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$2.3Kdisclosed Jun 10 · filed 9 days after the trade · late
  20. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  21. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$734Kdisclosed Jun 10 · filed 75 days after the trade · late
  22. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$2.3Mdisclosed Jun 10 · filed 83 days after the trade · late
  23. ▼ SELLPeter A Leidel DirectorMETC Ramaco Resources, Inc.$43.5Kdisclosed Jun 10 · filed 77 days after the trade · late
  24. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late
  25. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late